US drugs with noted supply-chain risks 5 times more likely to go into shortage in early COVID
In the first few months of the COVID-19 pandemic, US prescription drugs flagged for potential supply-chain disruptions were nearly five times more likely to go into shortage than those without such warnings, finds a University of Pittsburgh–led study. For …